IBS C News and Research

RSS
Commonwealth Lab expands access to new IBS test with national agreement with Quest

Commonwealth Lab expands access to new IBS test with national agreement with Quest

Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors

Sanofi terminates option and license agreement for Ardelyx's portfolio of NaP2b inhibitors

Swecure receives US patent approval for preventive allergy treatment

Swecure receives US patent approval for preventive allergy treatment

Ardelyx reports net income of $9.0 million for second quarter 2015

Ardelyx reports net income of $9.0 million for second quarter 2015

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Sheffield researchers win national awards for pioneering work on coeliac disease, IBS

Sheffield researchers win national awards for pioneering work on coeliac disease, IBS

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

Researchers find way to reverse clotting factor deficiency that triggers hemophilia A

Scientists find way to create therapeutic heat to treat people suffering from chronic muscle pain

Scientists find way to create therapeutic heat to treat people suffering from chronic muscle pain

Pinaverium offers quick relief from IBS symptoms

Pinaverium offers quick relief from IBS symptoms

Synthetic Biologics announces initiation of SYN-010 Phase 2 clinical trial for treatment of IBS-C

Synthetic Biologics announces initiation of SYN-010 Phase 2 clinical trial for treatment of IBS-C

A gastroenterologist guide to probiotics

A gastroenterologist guide to probiotics

Ardelyx signs termination agreement with AstraZeneca, regains rights to portfolio of NHE3 inhibitors

Ardelyx signs termination agreement with AstraZeneca, regains rights to portfolio of NHE3 inhibitors

Actavis announces FDA approval of VIBERZI (eluxadoline) for IBS-D treatment

Actavis announces FDA approval of VIBERZI (eluxadoline) for IBS-D treatment

Salix Pharmaceuticals receives FDA approval for Xifaxan 550 mg to treat IBS-D in adults

Salix Pharmaceuticals receives FDA approval for Xifaxan 550 mg to treat IBS-D in adults

Ardelyx reports positive results from tenapanor Phase 2b clinical trial in IBS-C patients

Ardelyx reports positive results from tenapanor Phase 2b clinical trial in IBS-C patients

Live, multi-strain probiotic drink may benefit people with ulcerative colitis

Live, multi-strain probiotic drink may benefit people with ulcerative colitis

Commonwealth announces availability of new ELISA-based blood test to quickly and reliably diagnose IBS

Commonwealth announces availability of new ELISA-based blood test to quickly and reliably diagnose IBS

Simple blood tests diagnose irritable bowel syndrome quickly and accurately

Simple blood tests diagnose irritable bowel syndrome quickly and accurately

Relaxation response has significant impact on patients with gastrointestinal disorders

Relaxation response has significant impact on patients with gastrointestinal disorders

New CU-Boulder study finds that hazardous drinking behaviors increase mortality rates

New CU-Boulder study finds that hazardous drinking behaviors increase mortality rates